We need to be a little careful with conclusions based the extrapolations in that slide. They are based on synthesising data from other trials and meta-data correlations analysis between diverse cognitive scoring measures, all of which are outside the Anavex controlled trials.
Of course the analysis is compelling, just not fact. Certainly interesting and promising being invested in $AVXL.
News 
Market Data 
Discover 
